Bryan Ball Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

ICPT Quotes by TradingView

Bryan Ball is Chief Qual. Officer & SVP Ops. of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 25,178 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2022, when has been sold 436 shares (Common Stock) at a price of $14.57 per share, resulting in proceeds of $6,353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.2K
0% 3M change
0% 12M change
Total Value Held $0

BRYAN BALL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2022
SELL
Payment of exercise price or tax liability
$6,353 $14.57 p/Share
436 Reduced 1.7%
25,178 Common Stock
Apr 11 2022
SELL
Payment of exercise price or tax liability
$9,128 $17.19 p/Share
531 Reduced 2.03%
25,614 Common Stock
Jan 27 2022
BUY
Grant, award, or other acquisition
-
3,600 Added 12.1%
26,145 Common Stock
Jan 11 2022
SELL
Payment of exercise price or tax liability
$41,318 $16.83 p/Share
2,455 Reduced 9.82%
22,545 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock

Also insider at

IMMU
IMMUNOMEDICS INC
Chief Quality Officer
BB

Bryan Ball

Chief Qual. Officer & SVP Ops.
Morristown, NJ

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ICPT